Sutro Biopharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
STRO Nasdaq 8731 https://www.sutrobio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Sutro Biopharma Inc

Sutro Biopharma Announces Oral Presentation at ASCO 2023 Featuring Data for Luveltamab Tazevibulin from the Phase 1 Dose-Expansion Study in Ovarian Cancer and the Initiation of the Phase 2/3 Pivotal Study REFRaME-O1 - Jun 3rd, 2023 8:00 pm
Sutro Biopharma to Participate in the Jefferies Healthcare Conference - May 31st, 2023 12:00 pm
Investors in Sutro Biopharma (NASDAQ:STRO) have unfortunately lost 51% over the last three years - May 28th, 2023 1:37 pm
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates - May 15th, 2023 1:15 pm
Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones - May 15th, 2023 12:00 pm
Sutro Biopharma to Present at the JMP Securities Life Sciences Conference - May 8th, 2023 12:00 pm
Sutro Biopharma, Inc. (STRO) Soars 11.3%: Is Further Upside Left in the Stock? - May 4th, 2023 7:52 am
IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Should You Buy? - May 2nd, 2023 2:02 pm
Sutro Biopharma, Inc. (STRO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - May 1st, 2023 2:01 pm
Sutro Biopharma Announces the Departure of President of Research & Chief Scientific Officer - Apr 27th, 2023 8:30 pm
Sutro Biopharma Presents Preclinical Data for its ROR1 Targeting Antibody Drug Conjugate STRO-003 at the AACR Annual Meeting 2023 - Apr 18th, 2023 5:30 pm
Investors Don't See Light At End Of Sutro Biopharma, Inc.'s (NASDAQ:STRO) Tunnel - Apr 17th, 2023 11:55 am
Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Misses Revenue Estimates - Mar 30th, 2023 10:45 pm
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones - Mar 30th, 2023 8:30 pm
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Mar 17th, 2023 8:01 pm
Sutro Biopharma, Inc. (NASDAQ:STRO) insider upped their holding by 4.3% earlier this year - Mar 5th, 2023 2:17 pm
Sutro Biopharma to Present at the Cowen 43rd Annual Health Care Conference - Mar 1st, 2023 1:00 pm
Sutro Biopharma Appoints Dr. Anne Borgman as Chief Medical Officer - Feb 28th, 2023 1:00 pm
Are Investors Undervaluing Sutro Biopharma, Inc. (NASDAQ:STRO) By 46%? - Jan 27th, 2023 11:31 am
Sutro Biopharma Posts Updated Data From Ovarian Cancer Candidate - Jan 10th, 2023 2:06 pm